Oral Health Insight Report
Antibiotics in dentistry sit between infection control, procedural access, patient expectations, and antimicrobial resistance. This report looks beyond prescribing frequency to the conditions that make unnecessary prescribing difficult to eliminate.
Audience: Dentists
Countries: 6
Survey records: 52
– headline finding
– Quick Read — Key Findings
Explore the full pattern across infection evidence, patient expectation, clinician variation, diagnostic uncertainty, and stewardship behaviour.
Background
Dental antibiotic decisions rarely occur in a vacuum. Pain, swelling, delayed access to definitive procedures, uncertainty about progression, patient expectations, and fear of complications can all create pressure to prescribe even when the most effective solution is procedural rather than pharmacological.
Current guidance makes this distinction explicit. The American Dental Association guideline for urgent pulpal and periapical conditions emphasizes definitive conservative dental treatment and limits systemic antibiotics to specific clinical situations, particularly when systemic involvement is present. CDC’s 2026 dental stewardship framework likewise highlights persistent variation and opportunities to standardize prescribing.
The survey therefore asks a deeper question than whether dentists know about antimicrobial resistance. It asks where knowledge loses momentum once the patient, the clock, the clinical uncertainty, and access to treatment all enter the same decision.
External context: CDC: Antibiotic Stewardship Strategies – Outpatient Dental Settings, 2026; American Dental Association: urgent dental antibiotic guideline.
The MDForLives survey includes dentists from United States, United Kingdom, Canada, Italy, France, and Germany.
Objective evidence of spreading or systemic infection is the strongest prescribing driver for 57.8%. Concern about progression before definitive treatment follows at 22.2%, with patient-specific medical risk factors at 15.6%.
What the pattern suggests: The dominant prescribing signal is clinically grounded. The stewardship problem therefore does not appear to come mainly from routine uncertainty about whether infection exists.
What may be behind it: Antibiotics become more difficult to avoid when infection appears to be spreading, when definitive treatment is delayed, or when patient-specific risk changes the consequences of waiting.
The four leading avoidable-prescribing scenarios cluster tightly: irreversible pulpitis without systemic involvement 26.7%, delayed access to definitive care 24.4%, patient expectation 24.4%, and post-procedural precautionary prescribing 22.2%.
What the pattern suggests: The near-even distribution suggests a system of small pressures rather than one dominant failure point. Any attempt to understand stewardship only through guideline knowledge misses access, pain management, precautionary habits, and patient demand.
What may be behind it: These situations share a common feature: antibiotics can become a temporary substitute for certainty, time, or immediate procedural resolution.
55.6% describe stewardship principles as inconsistently applied across providers or settings. Only 4.4% say they are applied very consistently.
What the pattern suggests: Variation appears to be a defining feature of the stewardship gap. Dentists are not describing an absence of stewardship language; they are describing uneven translation into everyday behavior.
What may be behind it: Prescribing habits can be shaped by training, local workflow, access to emergency treatment, risk tolerance, patient expectations, and how individual clinicians interpret similar clinical scenarios.
53.3% say managing patient expectations while limiting unnecessary prescribing creates the greatest tension. This is more than double the 22.2% who select balancing infection prevention with antimicrobial resistance.
What the pattern suggests: The hardest stewardship problem may be relational rather than pharmacological. A clinically appropriate non-antibiotic plan can still feel unsatisfactory to a patient seeking immediate relief or reassurance.
What may be behind it: Pain creates urgency, and antibiotics are familiar, tangible, and easy to perceive as active treatment. Explaining why a procedure, monitoring, or analgesic strategy better fits the condition can take more time than writing a prescription.
14.0% say prescribing has changed substantially and 53.5% see some improvement as antimicrobial resistance awareness grows. Yet 23.3% say awareness has increased more than behavior, and 55.6% still see stewardship inconsistency across providers or settings.
What the pattern suggests: The profession appears to be moving, but not uniformly. Awareness is no longer the main bottleneck; the remaining gap is translating awareness into consistent decisions across clinicians and situations.
What may be behind it: That interpretation fits the future priorities respondents select: patient education, dental training, and clearer evidence-based guidance all rank well ahead of enhanced diagnostic support tools.
When asked what is most likely to improve stewardship, respondents focus on patient education, professional training, and clearer guidance rather than on new diagnostic technology.
What the pattern suggests: The leading responses point to a consistency problem more than an information deficit. Dentists appear to see the next gains coming from better alignment between what clinicians know, what patients expect, and how prescribing guidance is applied in everyday care.
Why it matters: Awareness of antimicrobial resistance can rise without fully changing behaviour. Education and expectation management may matter because they shape the consultation in the moments when a patient wants immediate relief but an antibiotic is not the definitive treatment.
Delayed procedures, post-procedural habits, patient demand, and medicolegal concerns all appear beside the clinical infection signal. This makes antibiotic stewardship partly a workflow and communication issue.
Persistent but non-specific symptoms are more influential than patient pressure in moving clinicians away from standard pathways. This suggests that the trajectory of symptoms, not only the first presentation, is shaping suspicion.
Patient expectation appears both as an avoidable-prescribing scenario and as the largest source of decision tension. The data suggest that the stewardship conversation often begins before an antibiotic is clinically considered.
The survey suggests that antibiotic stewardship in dentistry has moved beyond a simple awareness problem. Most respondents see at least some improvement as antimicrobial resistance becomes more visible, and objective infection evidence remains the leading prescribing trigger.
The residual gap sits in the conditions around the prescription: patient expectations, variability between clinicians, delayed access to definitive treatment, post-procedural precaution, and fear of complications. None is dominant enough to explain the problem alone, but together they create a persistent background pressure toward prescribing.
That is why the strongest future signals are educational and communicative. Respondents place patient education, stewardship training, and clearer guidelines ahead of new diagnostic tools, revealing a belief that more consistent decisions may depend as much on shared understanding as on additional technology.
Direct answers to the questions healthcare professionals are most likely to ask about these findings.
You have read the summary
Direct, current answers to common questions around this topic.
